B1 research
Benfotiamine Nerve Research: Diabetes Studies Explained
Benfotiamine nerve research is mostly in diabetic neuropathy, and it is small. In the 6-week BENDIP trial of 165 people, one symptom score improved at 300 to 600 mg a day in one analysis. Another did not. SciatiEase lists 200 mg per 4 capsules, below the studied range.
Written by the SciatiEase label deskUpdated · 4 min read
What is benfotiamine, and how is it linked to nerves?
Benfotiamine is a fat-soluble form of thiamin, which is vitamin B1. The body converts it to thiamin (NIH ODS, Thiamin).
Thiamin matters to nerves because severe deficiency, called beriberi, mainly causes peripheral neuropathy and muscle wasting (NIH ODS, Thiamin). That is a deficiency link. It does not show that extra thiamin helps nerves in people who are not deficient.
Benfotiamine research asks a narrower question: does the fat-soluble form change symptoms in diabetic neuropathy?
Diabetic neuropathy, thiamin deficiency and sciatica are three separate conditions. Studies of one do not answer the others.
What did the benfotiamine nerve trials find?
The benfotiamine trials found modest, mixed results. The fact sheet counts three small placebo-controlled studies of 120 to 900 mg a day in diabetic neuropathy, with less severe symptoms. It adds that larger, longer studies are needed (NIH ODS, Thiamin).
The best known is BENDIP. It randomized 165 people to 600 mg, 300 mg or placebo for 6 weeks. The Neuropathy Symptom Score improved in the per-protocol analysis. In the intention-to-treat analysis the result was only borderline, and the Total Symptom Score did not differ (Stracke et al., BENDIP 2008).
Benefits were larger at 600 mg, and treatment was well tolerated.
| Item | Detail |
|---|---|
| People | 165 with diabetic polyneuropathy |
| Doses | 600 mg, 300 mg, or placebo daily |
| Length | 6 weeks |
| Symptom score (per-protocol) | Improved |
| Total Symptom Score | No difference |
How does SciatiEase's benfotiamine amount compare?
SciatiEase lists 200 mg of benfotiamine per serving of 4 capsules, and 100 mg at 2 capsules. Both are under the 300 to 600 mg used in BENDIP.
The trial people had diabetic nerve damage. Sciatica is a different problem (MedlinePlus, Sciatica). We do not transfer the trial result to SciatiEase, and the product was not tested in these studies. The brand's page lists 300 mg, but the panel says 200 mg, and we follow the panel.
- 4 capsules: 200 mg benfotiamine.
- 2 capsules: 100 mg benfotiamine.
- BENDIP doses: 300 and 600 mg a day.
- No upper limit is set for thiamin (NIH ODS, Thiamin).
The label line is on the benfotiamine page, and the vitamin family is on the B vitamins page.
SciatiEase: from $49.99 a bottle120 capsules · 1, 3 or 6 bottles · 180-day money-back guarantee
See packsWhat should people with diabetes ask before using benfotiamine?
People with diabetes should ask their doctor before adding any supplement. NIDDK advises talking with a doctor before using supplements for nerve problems (NIDDK, Peripheral Neuropathy).
Nerve damage from diabetes is best slowed by managing blood glucose, blood pressure and cholesterol, plus daily foot checks (NIDDK, Peripheral Neuropathy). A supplement does not replace those steps.
Keep taking prescribed medicine. New numbness, a foot wound, or weakness in both legs needs prompt medical care. Go to emergency care for numbness around the groin or bottom, bladder or bowel changes, or symptoms after an injury.
Bring the label
Show the amounts to your doctor.
Ask about your medicines
Include diabetes drugs and any other supplements.
Set a review date
Decide when to judge whether it is worth continuing.
The broader context is in the nerve supplements guide.
Order SciatiEase
Thinking of trying it? The bigger packs cost less per bottle.
Prices from the order page, October 18, 2026 (SciatiEase order page). One bottle is $69.00 plus $6.95 S&H. Every pack carries the 180-day money-back guarantee. Check your medicines first.
FAQ01
Quick answers on benfotiamine research
Is benfotiamine the same as vitamin B1?
Benfotiamine is a synthetic, fat-soluble form of thiamin, which is B1. The body converts it to thiamin (NIH ODS, Thiamin). It is related to B1 but is not identical, and trials of one form do not apply automatically to the other.
Did the BENDIP trial prove benfotiamine works?
No. One symptom score improved in the per-protocol analysis, but the intention-to-treat result was borderline and the Total Symptom Score did not differ (Stracke et al., BENDIP 2008). It is a hint worth testing in larger trials, not proof.
Is there a benfotiamine trial for sciatica?
We found none in our sources. Human work centers on diabetic neuropathy, and some animal studies look at nerve tissue. Rat results cannot be assumed to apply to people, so they only suggest what to test next.
Who wrote this02
Written and reviewed by
Pages built from the Supplement Facts panel, the brand pages and linked NIH, FDA, FTC, NHS and peer-reviewed sources.
Last updated . See our editorial standards and the way we check reviews. This website is run by Isciatiease, a U.S. desk for SciatiEase, not by the manufacturer or by SciatiEase Labs. Purchases made through our order links earn us a commission.
Keep reading
More about SciatiEase
U.S. desk for SciatiEase
Ready to try SciatiEase?
Check your medicines first, then pick a pack. Bigger packs cost less per bottle, and the 180-day money-back guarantee gives you time to judge it.
- Secure checkout on the brand page
- 180-day guarantee
- Ships from the U.S.
